FOLH1 and neoplasm: These preliminary data on [68Ga]Ga-PSMA indicate that it is important to consider the possibility of [68Ga]Ga-PSMA uptake in tumour entities beyond prostate cancer, even NEN, especially in patients showing [68Ga]Ga-PSMA uptake at sites that are uncommon for prostate cancer spread [61].